GSTM1 and infectious otitis media: Additionally, the AOM-treated mice receiving Losartan did not exhibit the same increase in rectal [Hb] for ‘Late tumor formers’ nor the extreme microvascular changes in varying vessel size and structure as the AOM alone group, pointing to the potential of ARBs to mitigate these effects.